TELATELA Bio, Inc.

Nasdaq telabio.com


$ 2.75 $ -0.03 (-1.08 %)    

Friday, 06-Sep-2024 15:59:49 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 2.75
$ 2.75 x 100
-- x --
-- - --
$ 2.54 - $ 9.52
44,138
na
67.96M
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 03-22-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-23-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 12-18-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lake-street-maintains-buy-on-tela-bio-lowers-price-target-to-8

Lake Street analyst Frank Takkinen maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $14 to $8.

 canaccord-genuity-maintains-buy-on-tela-bio-lowers-price-target-to-12

Canaccord Genuity analyst Caitlin Cronin maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $14 to...

 jmp-securities-maintains-market-outperform-on-tela-bio-lowers-price-target-to-12

JMP Securities analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target f...

 piper-sandler-maintains-overweight-on-tela-bio-lowers-price-target-to-8

Piper Sandler analyst Matt O'Brien maintains TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from $...

 tela-bio-q2-2024-gaap-eps-051-misses-044-estimate-sales-16091m-miss-18460m-estimate

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.44) by...

 canaccord-genuity-maintains-buy-on-tela-bio-maintains-14-price-target

Canaccord Genuity analyst Caitlin Cronin maintains TELA Bio (NASDAQ:TELA) with a Buy and maintains $14 price target.

 piper-sandler-reiterates-overweight-on-tela-bio-lowers-price-target-to-10

Piper Sandler analyst Matt O'Brien reiterates TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from ...

 tela-bio-q1-2024-adj-eps-054-misses-050-estimate-sales-16603m-beat-16319m-estimate

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.50) by...

 jmp-securities-reiterates-market-outperform-on-tela-bio-maintains-15-price-target

JMP Securities analyst David Turkaly reiterates TELA Bio (NASDAQ:TELA) with a Market Outperform and maintains $15 price target.

 piper-sandler-maintains-overweight-on-tela-bio-lowers-price-target-to-12

Piper Sandler analyst Matt O'Brien maintains TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from $...

 recap-tela-bio-q4-earnings
Recap: TELA Bio Q4 Earnings
03/21/2024 20:20:12

 tela-bio-q4-2023-gaap-eps-053-misses-044-estimate-sales-16998m-beat-16392m-estimate

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.44) by...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION